Online inquiry

IVTScrip™ mRNA-Human AMOT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17855MR)

This product GTTS-WK17855MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AMOT protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001113490.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 154796
UniProt ID Q4VCS5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AMOT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17855MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK13140MR IVTScrip™ mRNA-Human ADGRF5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADGRF5
GTTS-WK9175MR IVTScrip™ mRNA-Human ACTRT3, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTRT3
GTTS-WK0590MR IVTScrip™ mRNA-Human FBLN5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA FBLN5
GTTS-WK25695MR IVTScrip™ mRNA-Human ASB13, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASB13
GTTS-WK22042MR IVTScrip™ mRNA-Human ARL4C, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL4C
GTTS-WK22024MR IVTScrip™ mRNA-Human ARID3B, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARID3B
GTTS-WK23865MR IVTScrip™ mRNA-Human ARPC1A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARPC1A
GTTS-WK24681MR IVTScrip™ mRNA-Human ARHGAP10, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP10
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →